Pfizer to shutter or sell Irish plant that employs 136; Bayer launches Stivarga trial in liver cancer;

@FiercePharma: ICYMI - execs' bogeymen: Animal-rights extremists, disease activists and laid-off workers, security tells FAA. Report | Follow @FiercePharma

> Pfizer ($PFE) will close a plant in Little Island, Ireland, planning to consolidate its operations with another plant in nearby Ringaskiddy; the shutdown will affect 136 employees there, Irish media report, unless Pfizer can find a buyer for the facility. Report

> Bayer started a new, late-stage trial of its potential blockbuster treatment Stivarga, in patients with advanced liver cancer. Report

> The FDA approved new labeling for common insomnia drugs, including Sanofi's ($SNY) Ambien, that caution patients from driving or taking part in other activities that require alertness the next day, and recommend lower doses to minimize side effects. Report

> The FDA said it would review an application for broader use of Seattle Genetics' ($SGEN) lymphoma drug Adcetris. Report

> Biotech drug sales in Germany leapt 11% in 2012, compared with a 2.4% increase in drug spending on the whole, an industry association said. Report

Medical Device News

@FierceMedDev: Elixir snags CE mark for dissolvable stent. News | Follow @FierceMedDev

@MarkHFierce: Roche won crucial FDA approval for a companion diagnostic for lung cancer. Goes with Astellas' Tarceva. Release | Follow @MarkHFierce

 @DamianFierce: Analogic is lopping off 140 jobs in Colorado and Vancouver. More | Follow @DamianFierce

> Daktari Diagnostics reels in $7M as it preps for Scotland expansion. Story

> Vermillion private placement comes through. Item

Biotech News

@FierceBiotech: $VVUS announces proposed offering of convertible senior notes. Release | Follow @FierceBiotech

@JohnCFierce: Quintiles joins Merck KGaA's R&D command post in 5-year exclusive. News | Follow @JohnCFierce

@RyanMFierce: Billionaires back Kite Pharma in $20M raise for cancer immunotherapies. Article | Follow @RyanMFierce

> FDA OKs pinpoint prostate cancer radiation drug Xofigo from Bayer, Algeta. News

> New crowdfunding platform set to launch new biotechs. More

> Tokai lands $35M venture round for triple-threat prostate cancer drug. News

Drug Delivery News

@MichaelGFierce: Israeli team spurs nerve healing with implant-released gel. More | Follow @MichaelGFierce

> New polymers shatter to release drugs at specific target. Report

> Marina platform to deliver first-ever miRNA cancer drug for Mirna PhI. News

> Scripps study reveals new RNA-drug targeting potential. Article

> FDA accepts Merck's sublingual allergy med license application. Item

Biomarkers News

> Genome mutations reveal acute myeloid leukemia risk, potential drug targets. Story

> Biomarker trio enables blood Dx to map heart attack risk. More

> Bristol-Myers Squibb, Adaptive Biotechnologies ally for cancer biomarker development. More

> Fetus secretes hormone that could flag preeclampsia risk. Article

> 9 blood-based biomarkers correspond to amyloid plaque in the brain. Item

And Finally... Two in-vitro patties and special sauce on a bun? Researchers say engineered beef is on its way. Report

Suggested Articles

Which rollouts might suffer most? Those that treat chronic diseases, require doctors to administer them or face current competition, analysts say.

Novartis and Incyte will put their blockbuster JAK inhibitor into phase 3 clinical trials as a possible treatment for COVID-19, the drugmakers said.

The Cannes Lions canceled its advertising creativity conference for 2020 after media reports that many large ad agencies planned to opt out.